Acorda therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Acorda therapeutics Contact Number

Contact Acorda Therapeutics Inc. Acorda.com

2 hours ago Acorda.com Show details

Contact us by by web, phone, or email at our Acorda Therapeutics Inc. headquarters in Ardsley, New York, or our office in Chelsea, MA.

Phone: 9143474300

Category: Contact SupportShow more

Contact Acorda AMPYRA® (dalfampridine)

9 hours ago Ampyra.com Show details

888-881-1918Call AMPYRA Patient Support Services (APSS) for information about AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg, including help with insurance coverage or out-of-pocket cost for AMPYRA. By telephone toll-free 1-888-881-1918 Monday through Friday, from 8 AM to 8 PM ET. To report an adverse event, or if you experience any serious side

Category: Contact SupportShow more

Contact Us Acorda Therapeutics Inc

4 hours ago Ir.acorda.com Show details

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address.

Category: Contact SupportShow more

Acorda Therapeutics, Inc. Company Profile Ardsley, NY

7 hours ago Dnb.com Show details

Find company research, competitor information, contact details & financial data for Acorda Therapeutics, Inc. of Ardsley, NY. Get the latest business insights from Dun & Bradstreet.

Employees: 168
Cash and Cash Equivalents: $62.09
Accounts Receivable: $22.08
Location: 420 Saw Mill River Rd, Ardsley, 10502-2605, NY

Category: Contact NumberShow more

Acorda Therapeutics Crunchbase Company Profile & Funding

9 hours ago Crunchbase.com Show details

(914) 347-4300Contact Email [email protected]acorda.com Phone Number (914) 347-4300 Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI) and other disorders of the

Founded: 1995

Category: Contact NumberShow more

Acorda Therapeutics Biotechnology Company MS and Spinal

3 hours ago Acorda.com Show details

Acorda has acquired Biotie Therapies. We invite you to explore www.acorda.com to learn more about our company, including our continued development of …

Category: Tech SupportShow more

How to Contact Acorda AMPYRA® (dalfampridine)

Just Now Ampyra-hcp.com Show details

Indication. AMPYRA ® (dalfampridine) Extended Release Tablets, 10 mg, is the first and only brand medication indicated to improve walking in adults with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. Important Safety Information. AMPYRA is contraindicated in patients with history of seizure, moderate or severe renal impairment (CrCl ≤ 50 mL/min), or history

Category: Contact SupportShow more

For Patients Acorda Therapeutics

Just Now Acorda.com Show details

You are now leaving the Acorda.com site. By clicking "Ok", you will be leaving this website (sponsored by Acorda Therapeutics, Inc.) to enter an external and entirely independent website. Acorda.com provides this link as a service and assumes no responsibility for any information presented on …

Category: Contact NumberShow more

Acorda Therapeutics Company Profile Office Locations

6 hours ago Craft.co Show details

Acorda Therapeutics has 474 employees across 4 locations and $152.97 M in annual revenue in FY 2020. See insights on Acorda Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Category: Contact NumberShow more

Acorda Therapeutics Company Leadership Acorda.com

3 hours ago Acorda.com Show details

Ron Cohen, M.D., President and Chief Executive Officer, founded Acorda Therapeutics, Inc. in 1995.Previously he was a principal in the startup and an officer of Advanced Tissue Sciences, Inc., a biotechnology company engaged in the growth of human organ tissues for transplantation.

Category: Contact NumberShow more

About Acorda Therapeutics

8 hours ago Acorda.com Show details

You are now leaving the Acorda.com site. By clicking "Ok", you will be leaving this website (sponsored by Acorda Therapeutics, Inc.) to enter an external and entirely independent website. Acorda.com provides this link as a service and assumes no responsibility for any information presented on …

Category: Contact NumberShow more

Acorda Therapeutics, Inc. AL, CA, CT, DE, FL, IN, KS, LA

7 hours ago Bizapedia.com Show details

ACORDA THERAPEUTICS, INC. NORTH DAKOTA FOREIGN BUSINESS CORPORATION: WRITE REVIEW: Address: 420 Saw Mill River Rd Ardsley, NY 10502-2605: Registered Agent: C T Corporation System: Filing Date: November 06, 2009: File Number: 0000096965: Contact Us About The Company Profile For Acorda Therapeutics, Inc.

Category: Contact NumberShow more

Acorda Therapeutics Ireland Limited Irish Company Info

1 hours ago Vision-net.ie Show details

Acorda Therapeutics Ireland Limited was set up on Wednesday the 18th of October 2017. Their current partial address is Dublin, and the company status is Normal. The company's current directors have been the director of 0 other Irish companies between them. Acorda Therapeutics Ireland Limited has 1 …

Category: Contact NumberShow more

Acorda Therapeutics Inc Investors

4 hours ago Ir.acorda.com Show details

September 9, 2021 Acorda Therapeutics Announces Corporate Restructuring, Management Changes August 5, 2021 Acorda Therapeutics Reports Second Quarter 2021 Financial Results View News Archives

Category: Contact NumberShow more

RxAssist ACORDA THERAPEUTICS Patient Assist Program

8 hours ago Rxassist.org Show details

Patient Assistance Program. Patient assistance programs (PAPs) are programs created by drug companies, such as ACORDA THERAPEUTICS, to offer free or low cost drugs to individuals who are unable to pay for their medication. These Programs may also be called indigent drug programs, charitable drug programs or medication assistance programs.

Category: Contact NumberShow more

Acorda Therapeutics Inc. Privacy Policy Acorda.com

6 hours ago Acorda.com Show details

You are now leaving the Acorda.com site. By clicking "Ok", you will be leaving this website (sponsored by Acorda Therapeutics, Inc.) to enter an external and entirely independent website. Acorda.com provides this link as a service and assumes no responsibility for any information presented on …

Category: Contact NumberShow more

Acorda Therapeutics Inc Acorda Therapeutics Announces

9 hours ago Ir.acorda.com Show details

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has entered into distribution and supply agreements with Esteve Pharmaceuticals S.A (ESTEVE) to commercialize INBRIJA ® 33 mg (levodopa inhalation powder, hard capsules) in Spain. INBRIJA is indicated in the EU for the intermittent treatment of episodic motor fluctuations (OFF episodes) in adult patients with …

Category: Contact NumberShow more

Acorda Therapeutics, Inc. (ACOR) Company Profile

6 hours ago Stockanalysis.com Show details

Company profile for Acorda Therapeutics, Inc. (ACOR) with a description, list of executives, contact details and other key facts. Company profile for Acorda Therapeutics, Inc. (ACOR) with a description, list of executives, contact details and other key facts. CUSIP Number: 00484M106: ISIN Number: US00484M6012: Employer ID: 13-3831168: Key

Category: Contact NumberShow more

Acorda Therapeutics Inc Acorda Therapeutics Announces

2 hours ago Ir.acorda.com Show details

Scheduled to Reconvene August 28, 2020 at 9:00 a.m. Eastern Time at Company Headquarters to Vote on Proposal One Acorda Therapeutics, Inc. (Nasdaq: ACOR ) convened its Special Meeting of Stockholders on July 31, 2020, and stockholders approved proposals to authorize the Company’s Board of Directors to implement a reverse stock split, and to adjourn the meeting to …

Category: Contact NumberShow more

22250s000

5 hours ago Accessdata.fda.gov Show details

800-367-5109from your Acorda Therapeutics representative or field-based Medical Affairs staff. If you have any questions, please contact Acorda Therapeutics Medical Information Services at 1-800-367-5109. This letter is not intended to describe all important information associated with AMPYRA use.

Category: Contact NumberShow more

Acorda Therapeutics Inc Acorda Second Quarter 2021

Just Now Ir.acorda.com Show details

ARDSLEY, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its second quarter 2021 update and financial results on Thursday, August 5 at 4:30 p.m. ET. To participate in the Webcast/Conference Call, please use the following pre-registration links: To register for the Webcast, use the link below: …

Category: Contact NumberShow more

Acorda Therapeutics Grant Application Portal

2 hours ago Grantsportal.acorda.com Show details

By registering, you are authorizing Acorda Therapeutics, its agents, or vendors acting on behalf of Acorda Therapeutics to communicate with you, using the contact information and preferences you have provided, regarding Acorda and its products and services. You may contact

Category: Contact NumberShow more

Civitas Therapeutics Crunchbase Company Profile & Funding

Just Now Crunchbase.com Show details

617-660-4110Contact Email [email protected]civitastherapeutics.com Phone Number 617-660-4110 Civitas Therapeutics is a biopharmaceutical company that focuses on developing pulmonary delivery therapies.

Category: Contact NumberShow more

Acorda Therapeutics Inc Acorda Therapeutics Announces

2 hours ago Ir.acorda.com Show details

Acorda Therapeutics, Inc. (Nasdaq: ACOR) (the “Company”) today announced that it has entered into agreements with a limited number of institutional investors who are holders of the Company’s 1.75% Convertible Senior Notes due 2021 (the “Existing Convertible Notes”) to exchange $276 million aggregate principal amount of the Existing Convertible Notes for a combination of newly …

Category: Contact NumberShow more

Request a Representative INBRIJA® (levodopa inhalation

Just Now Inbrija-hcp.com Show details

COVID-19 Update: INBRIJA ® (levodopa inhalation powder) continues to be available through a dedicated specialty pharmacy network. INBRIJA ® (levodopa inhalation powder) continues to be available through a dedicated specialty pharmacy network. Since the initial outbreak of COVID-19, Acorda has been closely monitoring our supply chain for potential impact to the supply of our medicines.

Category: Contact NumberShow more

Corporation Information of ACORDA THERAPEUTICS, INC

Just Now Texas-corp.com Show details

002-06-15ACORDA THERAPEUTICS, INC. ACORDA THERAPEUTICS, INC. (Number: 11338311688) is located at 420 SAW MILL RIVER RD, ARDSLEY, NY 10502, established on 2002-06-15 (19 years ago). The final info updated on 2021-08-31, and the current status is Active.

Category: Contact NumberShow more

ACOR Acorda Therapeutics Inc. Stock Price & News WSJ

3 hours ago Wsj.com Show details

View the latest Acorda Therapeutics Inc. (ACOR) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Category: Contact NumberShow more

Acorda Therapeutics Inc Acorda Reports Second Quarter

8 hours ago Ir.acorda.com Show details

INBRIJA ® (levodopa inhalation powder) 2Q 2020 net revenue of $4.7 million AMPYRA ® (dalfampridine) 2Q 2020 net revenue of $26.1 million INBRIJA dispensed cartons increase 13% over 1Q 2020 Acorda Therapeutics, Inc. (NASDAQ: ACOR ) today provided a business update and reported its financial results for the second quarter ended June 30, 2020.

Category: Contact NumberShow more

Acorda Therapeutics Wikipedia

9 hours ago En.wikipedia.org Show details

Acorda Therapeutics, Inc. is an American biotechnology company based in Ardsley, New York.The company develops therapies that improve neurological function in people with Parkinson's disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) in the United States.

Category: Contact NumberShow more

ACORDA THERAPEUTICS, INC. :: New York (US) :: OpenCorporates

Just Now Opencorporates.com Show details

Free and open company data on New York (US) company ACORDA THERAPEUTICS, INC. (company number 2423574), 28 LIBERTY STREET, NEW YORK, NEW YORK, 10005

Category: Contact NumberShow more

AMPYRA Patient Support Services Center Free 60 Day Trial

5 hours ago Ampyra-hcp.com Show details

Office Contact Name: Contact Phone: NPI #: Services Center on behalf of Acorda Therapeutics, Inc. (“Acorda”) to be my designated agent and to act for me, a covered entity, as my business associate (as those terms are defined in 45 CFR Support Services Center’s toll-free number

Category: Support NumberShow more

Acorda Therapeutics Number of Employees 20062021 ACOR

6 hours ago Macrotrends.net Show details

Acorda Therapeutics number of employees from 2006 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Contact NumberShow more

420 Saw Mill River Rd, Ardsley, NY Acorda Therapeutics

2 hours ago Clustrmaps.com Show details

This address is #10 on the list of city addresses by the number of businesses registered there. This address is #4 among addresses in the city by the number of AMS cargo manifests. Historical WHOIS database shows that this address was mentioned in the registration documents for 46 domain names. Acorda Therapeutics, Inc is the name of the

Category: Contact NumberShow more

How Do Analysts Feel About Acorda Therapeutics Inc. (ACOR

2 hours ago Baxterreport.com Show details

The total number of common shares currently owned by the public is 9.47 million. ACOR does have institutional investors; and they hold 39.40% of the stock. Acorda Therapeutics Inc. – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 0 new insider purchases involving 0 shares.

Category: Contact NumberShow more

Echo Therapeutics Crunchbase Company Profile & Funding

7 hours ago Crunchbase.com Show details

(215) 717-4100Legal Name Echo Therapeutics Inc. Stock Symbol OTCPINK:ECTE. Company Type For Profit. Contact Email [email protected] Phone Number (215) 717-4100. Echo Therapeutics is a medical device company with deep expertise in advanced skin permeation technology. Echo is developing its Symphony® CGM System as a non-invasive, wireless, continuous glucose

Category: Contact NumberShow more

INBRIJA, A Canada Trademark of ACORDA THERAPEUTICS, INC

Just Now Trademarkelite.com Show details

INBRIJA is a canadian trademark and brand of ACORDA THERAPEUTICS, INC., Ardsley, NY 10502,UNITED STATES. This trademark was filed to the Canadian Intellectual Property Office on Monday, February 8, 2016. The INBRIJA is under the trademark classification: Medical Instrument Products; The INBRIJA trademark covers Medical devices, namely inhaler and nebulizer delivery …

Category: Contact NumberShow more

Leadership Team — Constant Therapeutics

8 hours ago Constanttherapeutics.com Show details

Dr. Franklin is a founder of Constant Therapeutics and has served as its President and CEO since its inception. He was a director of Raptor Pharmaceuticals, until its sale to Horizon Pharma in 2016. Elizabeth Wagner, MS, MBA, Chief Operating Officer. Miss Wagner has served as VP Corporate Development from October 2011 through 2015 and has been

Category: Contact NumberShow more

Acorda Therapeutics First Quarter 2021 Update: Webcast

4 hours ago Finance.yahoo.com Show details

Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its first quarter 2021 update and financial results on Thursday, May 6 at 4:30 p.m. ET.

Category: Contact NumberShow more

Acorda Therapeutics : Announces Corporate Restructuring

9 hours ago Marketscreener.com Show details

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced a corporate restructuring to reduce costs and more closely align operating expenses with expected revenue. The Company also announced changes to its management team. Corporate Restructuring. As a result of the restructuring, the Company is reducing headcount by 15%.

Category: Contact NumberShow more

Acorda Therapeutics Inc. (ACOR) Quarterly Performance is

7 hours ago Investchronicle.com Show details

Acorda Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $8.66 on 01/20/21, with the lowest value was $3.37 for the same time period, recorded on 01/04/21.

Category: Contact NumberShow more

Acorda Second Quarter 2021 Update: Webcast/Conference Call

Just Now Finance.yahoo.com Show details

ARDSLEY, N.Y., July 30, 2021--Acorda Second Quarter 2021 Update: Webcast/Conference Call Scheduled for August 5, 2021

Category: Contact NumberShow more

ACORDA THERAPEUTICS, INC. REVERSE SPLIT OPTION …

Just Now Infomemo.theocc.com Show details

Acorda Therapeutics, Inc. (ACOR) has announced a 1-for-6 reverse stock split. As a result of the reverse stock split, each ACOR Common Share will be converted into the right to receive approximately 0.166667 (New) Acorda Therapeutics, Inc. Common Shares. The reverse stock split will become effective before the market open on January 4, 2021.

Category: Contact NumberShow more

ACORDA THERAPEUTICS, INC. : Shareholders Board Members

Just Now Marketscreener.com Show details

Acorda Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on developing therapies that restore function and improve the lives of people with neurological disorders.

Category: Contact NumberShow more

pressrelease.htm SEC.gov HOME

3 hours ago Sec.gov Show details

(917) 783-0251CONTACT: Tierney Saccavino. Acorda Therapeutics (917) 783-0251. Acorda Therapeutics is a biotechnology company developing therapies for multiple sclerosis, spinal cord injury and related nervous system disorders. The Company's pipeline includes a number of products in development for the treatment, regeneration and repair of the spinal

Category: Home PhoneShow more

Abeona Therapeutics Crunchbase Company Profile & Funding

9 hours ago Crunchbase.com Show details

Contact Email [email protected]abeonatherapeutics.com. Phone Number (216)287-5408. Abeona Therapeutics is developing gene therapy-based potential cures for the deadly childhood diseases Sanfilippo (SF) Syndrome Type A and Type B. Its multi-platform expertise across the manufacture, delivery, development, and discovery of the novel gene and cell

Category: Contact NumberShow more

Acorda Therapeutics First Quarter 2021 Update: Webcast

Just Now Businesswire.com Show details

(917) 783-0251Acorda Therapeutics First Quarter 2021 Update: Webcast/Conference Call Scheduled for May 6, 2021 Contacts Tierney Saccavino (917) 783-0251 [email protected]acorda.com

Category: Contact NumberShow more

Acorda (ACOR) Q1 Earnings Lag Estimates, Revenues Fall Y/Y

3 hours ago Finance.yahoo.com Show details

Acorda Therapeutics, Inc. ACOR reported first-quarter 2020 loss per share of 51 cents, wider than the Zacks Consensus Estimate of a loss of 35 …

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What kind of company is Acorda Therapeutics Inc?

Acorda Therapeutics Inc. is an American biotechnology company based in Ardsley, New York. The company develops drugs to improve therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system.

When did Acorda Therapeutics acquire Civitas Therapeutics?

Inbrija is approved by the FDA and the EU. In September 2014, the company acquired Civitas Therapeutics for US$525 million, gaining the Phase III Parkinson’s drug, CVT-301, the migraine drug CVT-427 and rights to the ARCUS pulmonary delivery system. Th ARCUS technology allows for the administration of drugs by inhalation.

What can Acorda Therapeutics do for Parkinson's disease?

About Acorda Therapeutics Acorda Therapeutics develops therapies to restore function and improve the lives of people with neurological disorders. INBRIJA^® (levodopa inhalation powder) is approved for intermittent treatment of OFF episodes in adults with Parkinson’s disease treated with carbidopa/levodopa.

How many shares of Acorda common stock are there?

Pursuant to the reverse stock split, every six shares of Acorda’s issued and outstanding common stock were automatically combined and converted into one issued and outstanding share of common stock, and there was a proportionate reduction in the number of shares of the Company’s authorized common stock, from 370,000,000 to 61,666,666.

Popular Brands

Amazon
Abbvie
Aia
Asml
Apple
Att
Amgen
Adobe
Aptar
Acc
Adidas
Aak
Aes
Asx